Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 31, 2018
Advaxis to Host Business Update and Second Quarter 2018 Financial Results Conference Call on June 7, 2018
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announced today the upcoming release of financial ...
May 31, 2018
Zealand Pharma to present new clinical Phase 2 results on glepaglutide for the treatment of short bowel syndrome at the DDW conference in the U.S.
Copenhagen, May 31, 2018 - Zealand Pharma ("Zealand"), announces that Rahim M. Naimi, MD and Mark Hvistendahl, MSc in clinical nutrition, both Department of Gastroenterology, ...
May 30, 2018
Keryx Pharmaceuticals Announces Upcoming Investor Presentations
BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today ...
May 30, 2018
BrainStorm Cell Therapeutics to Provide Corporate Update at the BIO International Convention
NEW YORK and PETACH TIKVAH, Israel, May 30, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for ...
May 30, 2018
PureTech Health to Present at Jefferies 2018 Global Healthcare Conference
BOSTON--(BUSINESS WIRE)--PureTech Health plc (PRTC.L) (“PureTech Health”), an advanced, clinical-stage biopharmaceutical company, announced today that Joep Muijrers, Ph.D., Chief Financial Officer at PureTech Health, will ...
May 30, 2018
TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom of VVA, Due to Menopause
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved IMVEXXY (estradiol vaginal ...
May 30, 2018
Aimmune Therapeutics Announces New Pan-European Study Showing Significant Psychosocial Burden Associated With Peanut Allergy
BRISBANE, Calif. & MUNICH--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that data from a new ...
May 30, 2018
BioTime to Present at the 8th Annual LD Micro Invitational
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that Russell Skibsted, Chief Financial Officer of BioTime, ...
May 30, 2018
Heat Biologics to Present at the 2018 BIO International Convention
DURHAM, NC / ACCESSWIRE / May 30, 2018 / Heat Biologics, Inc. (HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system ...
May 30, 2018
Arrowhead Pharmaceuticals to Present at Upcoming June 2018 Conferences
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it is scheduled to make presentations at the following upcoming events: Jefferies 2018 Global Healthcare Conference ...
May 30, 2018
Tyme Appoints Pharma Executive Don DeGolyer to Board of Directors
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Tyme, Inc. (TYME), a clinical-stage biotechnology company developing cancer therapeutics, today announced the appointment of Don DeGolyer ...
May 30, 2018
Mustang Bio Announces Preclinical Data on Potency of its CAR T Cells in Glioblastoma Published in JCI Insight
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a Fortress Biotech (FBIO) Company focused on the development of novel immunotherapies ...
May 30, 2018
Arrowhead Completes Enrollment in Single Dose Portion of Phase 1/2 Study of ARO-HBV
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it has completed enrollment and dosing of all 5 planned cohorts of healthy adult volunteers in ...
May 30, 2018
Auris Medical to Host Key Opinion Leader Call Focused on AM-201 Program for Treating Major Side Effects of Antipsychotics on June 11, 2018
Zug, Switzerland, May 30, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
May 30, 2018
Eiger BioPharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference
PALO ALTO, Calif., May 30, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on bringing to market novel product candidates for the treatment of rare ...
May 30, 2018
TRACON Pharmaceuticals Appoints Biotech Industry Veteran Mark Wiggins as Chief Business Officer
SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a biopharmaceutical company that develops targeted therapies for cancer and wet age-related macular degeneration, ...
May 30, 2018
PolarityTE to Present at the Jefferies 2018 Global Healthcare Conference
SALT LAKE CITY, May 30, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (COOL) today announced it will present at the Jefferies 2018 Global Healthcare Conference on ...
May 30, 2018
RedHill Biopharma to Present Positive Phase II Results of BEKINDA® for IBS-D at Digestive Disease Week 2018
TEL-AVIV, Israel and RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company ...
May 30, 2018
AzurRx Announces Appointment of Dr. James Pennington as Chief Medical Officer
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies ...
May 30, 2018
Minerva Neurosciences to Present at Jefferies 2018 Global Healthcare Conference on June 6, 2018
WALTHAM, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat ...
Page 37 of 117